Novel DNA for expression of delta-aminolevulinic acid synthetase and related method
AssigneeEli Lilly and Company
InventorsMartin Bard, Thomas D. Ingolia
Life of this patent
Estimating the term…
Abstract
The present invention is a novel method for maintaining and selecting recombinant DNA-containing host cells wherein the DNA encoding a selectable phenotype and the DNA encoding a useful polypeptide are the same. The aforementioned DNA is useful for expressing .delta.-aminolevulinic acid synthetase (ALAS) for the ultimate expression of .delta.-aminolevulinic acid (ALA) in yeast and related organisms. The invention further comprises plasmids pIT300, pIT301, pIT302, pIT304, pIT305, pIT306 and related Saccharomyces ALA deficient transformants. ALA is a five carbon amino acid that is useful as a light dependent herbicide.
Claims7
A method for maintaining and selecting a recombinant DNA-containing Saccharomyces cell comprising:
- (a) transforming a delta-aminolevulinic acid deficient Saccharomyces cell with a recombinant DNA cloning vector carrying a gene encoding delta-amino-levulinic acid synthetase, expression of which results in the production of delta-aminolevulinic acid in said transformed cell, and
- (b) culturing the cell transformed in step (a) in a delta-aminolevulinic acid-free culture medium under conditions suitable for growth and expression of said gene encoding synthetase, wherein said recombinant DNA cloning vector is selected from the group consisting of plasmid pIT300, pIT301, pIT302, pIT304, pIT305, and pIT306.
Dependencies are inferred from the claim text.